Phastar announced as Premier & Conference Dinner Sponsor of ACDM22
Date: July 1, 2021
The Association for Clinical Data Management is delighted to announce that Phastar are to be Premier & Conference Dinner Sponsor of ACDM22.
PHASTAR is a global CRO offering data management, data science, statistical consulting and clinical trial reporting services by providing expert consultants and managing and delivering in-house projects, FSP style arrangements and preferred partnerships. PHASTAR currently has 12 global offices (United States, United Kingdom, Australia, Germany, Kenya and Japan).
ACDM22 is the 2022 Annual Conference of the Association for Clinical Data Management and is being held in Edinburgh, Scotland, from the 13th-15th March 2022.
Explore More News
AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?
At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .
Read More
Newsletter Committee: Meet Neha
The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee.
Neha shares . . .
Read More
Newsletter Committee: Meet Sylvain
The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .
Read More
Welcome VHypotenuse as a corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .
Read More
Newsletter Committee: Meet Marta
The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .
Read More
AI model trained on de-identified data from 57 million people
Researchers at UCL have trained an AI model using de-identified data from 57 million . . .
Read More
ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released
The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .
Read More
ICH E6(R3) Guideline reaches Step 4 of the ICH Process
ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025.
The guideline . . .
Read More
U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties
The U.S. Food and Drug Administration has issued its first guidance on the use of . . .
Read More
ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025
As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .
Read More
Audit Trail Review DMEG Update – New Guide
The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .
Read More
Risk Based Quality Management DMEG Update – Recent Discussions
This year our focus has switched away from generalised RBQM to applying risk-based . . .
Read More
